OXFORD, UK -- PharmaVentures is pleased to announce that it has acted as advisor on deal terms to Plethora Solutions Holdings on their recently signed Licensing Agreement with Recordati to commercialise PSD502™, a novel treatment for premature ejaculation. Under the terms of the agreement Plethora are expected to receive upfront and milestone payments of up to €46 million plus royalties. Stephen Waterman, Vice President, who led the PharmaVentures team on the deal commented: "We are delighted to have worked with Plethora on the deal terms of this important licensing agreement".
Fintan Walton, Chief Executive, PharmaVentures, Ltd added: "We would like to congratulate Plethora on their licensing agreement with Recordati".
PharmaVentures is a premier transaction advisory firm; a world leader in partnering, M&A deals and strategic alliances. Our unrivalled bank of specialist experience, deal analytics and network of contacts among innovators and large pharma makes us uniquely placed to support your business in all aspects of deal making and strategic planning. PharmaVentures is well known for its deep insight into deal structures and its success for generating partnering interest.
Find out more www.pharmaventures.com
Our services include:
M&A (divestments, mergers, acquisitions and strategic transactions)
Strategy (commercialisation, deal strategy, due diligence, market entry)
Valuation and Positioning (licensing, M&A, fund raising & expert testimonies)
Licensing (in and out licensing)
Expert Testimony (patent infringement, deal disagreements, taxation, determining damages)
Now in its 22nd year, PharmaVentures is based in Oxford, UK, and employs over 18 people.
About Plethora
Plethora is headquartered in the UK and is listed on the London Stock Exchange (AIM: PLE
LN). Further information is available at www.plethorasolutions.co.uk
Plethora is focused on commercializing PSD502™ for the treatment of premature ejaculation with strategic marketing partners and obtaining NDA approval for PSD502™ with the FDA.
Technology news on Global TechWire, reporting the business of life
sciences and innovation. Published by Innovative Public Relations, Inc.,
a Research Triangle, North Carolina based publicity and branding
consultancy. David Menzies, President. www.innovativepublicrelations.com.
